3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
9
Lymphoma, Mantle-Cell
8
Breast Neoplasms
7
Lymphoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, T-Cell
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma, B-Cell
5
Recurrence
4
Neuroblastoma
4
Myelodysplastic Syndromes
4
Mycosis Fungoides
4
Multiple Myeloma
4
Lymphoma, T-Cell, Cutaneous
4
Leukemia
4
Congenital Abnormalities
4
Carcinoma, Non-Small-Cell Lung
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Erythroblastic, Acute
3
Glioblastoma
3
Burkitt Lymphoma
3
Interventions
Fluorouracil
13
Cisplatin
7
Radiotherapy
6
Specimen Handling
5
Mitomycin
5
Capecitabine
5
pembrolizumab
4
dehydroftorafur
4
Radiation
4
Drug Therapy
4
Cetuximab
4
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
Biopsy
3
tislelizumab
2
durvalumab
2
aldesleukin
2
VGX-3100
2
Platinum
2
Mitozytrex
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
1,2-diaminocyclohexaneplatinum II citrate
2
toripalimab
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
spartalizumab
1
rocakinogene sifuplasmid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Anus Neoplasms
×
Vorinostat
×
Clear all
NCT04357873
2025-02-19
PEVOsq
UNICANCER
Phase 2
Completed
112 enrolled